TrialBeacon
USClinicalTrials.govClinical trialPhase 1Not yet recruiting

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Open the official recordBack

Official record

Identifier
NCT05038098
Recruiting locations

country

United States
Interventions studied
GastrectomyIndocyanine GreenIron Conjugated Polymers in Saline Suspension
Lead sponsor
M.D. Anderson Cancer Center
Target enrolment
20 participants
Study type
INTERVENTIONAL
Phase
Phase 1
Status
Not yet recruiting
First posted
Sep 8, 2021
Last updated on the registry
Aug 14, 2026
Age
18 Years
Sex
ALL
Study contact
The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Age 18 or older
* Willing to provide informed consent
* Biopsy proven gastric cancer, undergoing curative-intent gastrectomy
* No distant metastases
* Pathologic diagnosis of gastric adenocarcinoma
* Pre-treatment endoscopic measurement of less than or equal to 4 cm in diameter of the gastric cancer

Exclusion Criteria:

* Contraindications to surgery +/- adjuvant therapy
* Allergy or intolerance to iron oxide compounds
* Allergy or intolerance to iodides
* Iron overload disorder
* Pregnant or lactating women\*

  * Use of contraception is required for females during the study. Male patients who are sexually active with a female of childbearing potential are allowed for study enrollment and will not require use of contraception
Indexed under
Gastric Cancer